Vaccine

CureVac Swiss AG Initiates Rolling Submission Process for mRNA-based COVID-19 Vaccine Candidate, CVnCoV, with Swissmedic

9 months ago user

Rolling submission to accelerate time to marketing authorization of CVnCoV in SwitzerlandReview process started with submission of first CVnCoV data...

Humanity Supersedes Technology with Covid Vaccines

12 months ago user

Lessons from the most important tech adoption of our century: the COVID-19 vaccine By Cameron Turner, VP Data Science and...

CureVac’s COVID-19 Vaccine Candidate, CVnCoV, Demonstrated Efficient Protection of Non-Human Primates During SARS-CoV-2 Challenge Infection

1 year ago user

Data provided further evidence on immunogenicity and protective efficacy of CVnCoV ∙ Induction of robust antibody and T cell responses...

XVIVO’s Kidney Assist Transport Receives 510(k) Clearance by US FDA, Which Is XVIVO’s First Regulatory Cleared Product for Abdominal Transplantation in the US

2 days ago Staff

Community Cares Rx Saved Patients More than $1B on Prescriptions in 2021

2 days ago Staff

News

LevelJump Announces $2.5 Million Non-Brokered Private Placement

2 days ago Staff

World of Concrete 2022 Wrapped a Highly Productive and Well-Attended Event, Fueling Industry Connection and Advancement

2 days ago Staff

Cybeats Joins OASIS Open; Congratulates Cybeats Advisor, Duncan Sparrell, on Winning OASIS Distinguished Contributor Award

2 days ago Staff

error: Content is protected !!

You may have missed